scispace - formally typeset
Open AccessJournal ArticleDOI

Integrated care pathways for airway diseases (AIRWAYS-ICPs).

Jean Bousquet, +224 more
- 01 Aug 2014 - 
- Vol. 44, Iss: 2, pp 304-323
TLDR
The AIRWAYS-ICP (Integrated Care Pathways for Airway Diseases) as mentioned in this paper is a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions.
Abstract
The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions. AIRWAYS-ICPs has strategic relevance to the European Union Health Strategy and will add value to existing public health knowledge by: 1) proposing a common framework of care pathways for chronic respiratory diseases, which will facilitate comparability and trans-national initiatives; 2) informing cost-effective policy development, strengthening in particular those on smoking and environmental exposure; 3) aiding risk stratification in chronic disease patients, using a common strategy; 4) having a significant impact on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long-term (healthy ageing); 5) proposing a common simulation tool to assist physicians; and 6) ultimately reducing the healthcare burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life. In the longer term, the incidence of disease may be reduced by innovative prevention strategies. AIRWAYS-ICPs was initiated by Area 5 of the Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing. All stakeholders are involved (health and social care, patients, and policy makers).

read more

Citations
More filters
Journal ArticleDOI

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan Brozek, +59 more
TL;DR: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR, addressing the relative merits of using oral H1‐antihistamines, intranasal H1-antihistsamines, IntranasAL corticosteroids, and leukotriene receptor antagonists either alone or in combination.
Journal ArticleDOI

EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.

TL;DR: The European Academy of Allergy and Clinical Immunology has developed a clinical practice guideline providing evidence‐based recommendations for the use of house dust mites (HDM) AIT as add‐on treatment for HDM‐driven allergic asthma.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis)

Jean Bousquet, +261 more
TL;DR: The MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis) as discussed by the authors is a simple system centred around the patient which was devised to fill many of these gaps using Information and Communications Technology (ICT) tools and a clinical decision support system (CDSS) based on the most widely used guideline in allergy and its asthma comorbidity (ARIA 2015 revision).
Journal ArticleDOI

Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

Josep M. Antó, +89 more
TL;DR: The translational component of MeDALL is shown by the identification of a novel allergic phenotype characterized by polysensitization and multimorbidity, which is associated with the frequency, persistence, and severity of allergic symptoms.
Journal ArticleDOI

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

Jean Bousquet, +276 more
- 01 Nov 2015 - 
TL;DR: MASK appears to be an advanced, global and integrated ICT answer for many unmet needs in allergic diseases which will improve policies and standards.
References
More filters
Journal ArticleDOI

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

TL;DR: The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.
Journal ArticleDOI

Allergic Rhinitis and Its Impact on Asthma

TL;DR: This systematic review and meta-analyses confirmed the findings of a previous study published in “Rhinitis and Asthma: Causes and Prevention, 2nd Ed.” (2015) as well as new findings of “Mechanisms of Respiratory Disease and Allergology,” which confirmed the role of EMTs in the development of these diseases.
Related Papers (5)

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Jean Bousquet, +95 more
- 01 Apr 2008 - 

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

Jean Bousquet, +276 more
- 01 Nov 2015 - 

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Jean Bousquet, +49 more

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

Jean Bousquet, +318 more